Abstracts tagged "fatigue and systemic lupus erythematosus (SLE)"

Abstract Number: 1664 • 2018 ACR/ARHP Annual Meeting
Fatigue Measurements in Systemic Lupus Erythematosus
Ariane Barbacki¹, Michelle Petri², J. Antonio Avina-Zubieta³, Graciela S. Alarcón⁴ and Sasha Bernatsky⁵, ¹McGill University, Montreal, QC, Canada, ²Medicine (Rheumatology), Johns Hopkins University School of Medicine, Baltimore, MD, ³Division of Rheumatology, Department of Medicine, University of British Columbia, Vancouver, BC, Canada, ⁴University of Alabama at Birmingham, Birmingham, AL, ⁵Divisions of Rheumatology and Clinical Epidemiology, McGill University Health Centre, Montreal, QC, Canada
Background/Purpose: Fatigue is one of the most frequent and disabling issues in systemic lupus erythematosus (SLE). It is, however, difficult to quantify. The Ad Hoc…
Abstract Number: 2672 • 2018 ACR/ARHP Annual Meeting
Serum Vitamin D Levels and Its Effect on Disease Activity and Fatigue in Systemic Lupus Erythematosus Patients
Radka Moravcova¹, Hana Ciferska², Marta Olejarova^3,4, Dana Tegzova⁵, Jakub Zavada⁶ and Milada Lösterova¹, ¹Institute of Rheumatology and Department of Rheumatology, 1st Faculty of Medicine, Charles University in Prague, Czech Republic, Praque, Czech Republic, ²Institute of Rheumatology and Department of Rheumatology, 1st Faculty of Medicine, Charles University in Prague, Czech Republic, Prague, Czech Republic, ³Department of Experimental Rheumatology, 1st Faculty of Medicine, Institute of Rheumatology, Charles University in Prague, Prague, Czech Republic, ⁴Institute of Rheumatology and Department of Rheumatology, 1st Faculty of Medicine, Charles University in Prague, Prague, Czech Republic, ⁵Institute of Rheumatology and Rheumatological Clinic of 1st Medical Faculty, Charles University, Prague, Prague, Czech Republic, ⁶Institute of Rheumatology and Department of Rheumatology, 1st Faculty of Medicine, Charles University, Prague, Czech Republic
Background/Purpose: Systemic lupus erythematosus (SLE) is a chronic autoimmune inflammatory disease involving many organs and systems. Evidences show that vitamin D plays an important role…
Abstract Number: 1761 • 2016 ACR/ARHP Annual Meeting
Fatigue in Patients with Systemic Lupus Erythematosus Is Independent of Their Disease Activity but Dependent on Their Damage Accrual and Body Mass Index
Adam Munday¹, Zerai G. Manna¹, Sarfaraz Hasni¹, Randall Keyser², Liana Wooten² and Ann Biehl³, ¹National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD, ²George Mason University Department of Rehabilitation Science, Fairfax, VA, ³Department of Pharmacy, National Institutes of Health Clinical Center, Bethesda, MD
Background/Purpose: Fatigue is omnipresent in patients with SLE. According to one study 80-90 % of the subjects report some degree of fatigue. This has huge…
Abstract Number: 1821 • 2015 ACR/ARHP Annual Meeting
Leptin, Adiponectin, and Resistin As Serum Markers of Fatigue in Systemic Lupus Erythematosus: A Pilot Study
Mary Mahieu¹, Grace Ahn², Joan S. Chmiel³, Dorothy D. Dunlop⁴, Irene Helenowski³, Pamela Semanik⁵, Jing Song⁴, Rowland W. Chang³ and Rosalind Ramsey-Goldman⁶, ¹Rheumatology, Northwestern University Feinberg School of Medicine, Chicago, IL, ²Rheumatology, Falls Medical Specialists, Baltimore, MD, ³Preventive Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, ⁴Institute for Healthcare Studies, Northwestern University Feinberg School of Medicine, Chicago, IL, ⁵Nursing, Rush University College of Nursing, Chicago, IL, ⁶Northwestern University Feinberg School of Medicine, Chicago, IL
Background/Purpose: Fatigue, a common symptom in systemic lupus erythematosus (SLE) patients, is ameliorated by physical activity. Adiposity and adipokines may be associated with patient-reported fatigue.…
Abstract Number: 2241 • 2012 ACR/ARHP Annual Meeting
Efficacy of Belimumab in Systemic Lupus Erythematosus Patients with High Baseline Disease Activity
Ann E. Clarke¹, Susan Manzi², Michelle Petri³, Richard Furie⁴, Ronald F. van Vollenhoven⁵, Simon Cooper⁶, Z. John Zhong⁶, William W. Freimuth⁶ and Arthur Weinstein⁷, ¹Division of Rheumatology, University of Calgary, Alberta, Calgary, AB, Canada, ²Division of Rheumatology, University of Pittsburgh School of Medicine, Pittsburgh, PA, ³Johns Hopkins University School of Medicine, Baltimore, MD, ⁴North Shore-LIJ Health System, Lake Success, NY, ⁵Karolinska University Hospital, Stockholm, Sweden, ⁶Human Genome Sciences, Inc., Rockville, MD, ⁷Washington Hospital Center, Washington, DC
Background/Purpose: To assess the efficacy of belimumab in patients with SLE who had high disease activity at baseline, as defined by SELENA-SLEDAI score ≥10. Methods: In…
Abstract Number: 1554 • 2012 ACR/ARHP Annual Meeting
Clusters of Fatigue- a Comparison Between Persons with Systemic Lupus Erythematosus and Age and Gender Matched Controls
Susanne Pettersson¹, Karin Eriksson², Carina Boström², Elisabet Svenungsson¹, Iva Gunnarsson¹ and Elisabet MB Welin Henriksson³, ¹Department of Medicine, Rheumatology Unit, Karolinska Institutet, Stockholm, Sweden, ²Department of Neurobiology, Care Sciences and Society,, Division of Physiotherapy, Karolinska Institutet Huddinge, Stockholm, Sweden, ³Medicine, Karolinska Institutet Rheum, Stockholm, Sweden
Background/Purpose: The aim (1) of this study was to explore fatigue in patients with SLE with age and gender match controls using cluster analysis and…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].